OpenAI’s AI video generator Sora is officially done, less than a year after it went viral. At first glance, it’s easy to ...

The Java ecosystem has historically been blessed with great IDEs to work with, including NetBeans, Eclipse and IntelliJ from JetBrains. However, in recent years Microsoft's Visual Studio Code editor ...

PCWorld demonstrates how OpenAI’s Codex can generate a complete personal homepage in just 56 seconds using simple prompts and ...

OpenAI is shutting down its social media app Sora, which went viral last fall as a place to share short-form videos generated ...

Discover how CIOs can leverage AI to modernize legacy programming languages, reduce technical debt, and enhance operational ...

'The Times of India' brings you 'Hack of the Day'—a new weekday series of quick, practical solutions to everyday hassles. Each hack is designed to save you time, money or stress, using tools and ...

Which AI should I use to generate viral Holi images? The most obvious way to transform images into different styles is Google's Gemini AI. The model, which now runs on the Nano Banana 2, can apply ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...

(Bloomberg) --Generate Biomedicines Inc. raised $400 million in an initial public offering, pricing its shares at the midpoint of the marketed range. The Somerville, Massachusetts-based drug developer ...

I recently saw a tweet showing how Google has acquired companies over the years and built products around them. Here is the link to the tweet if you want. Now, Google made another announcement: Google ...

Ayyoun is a staff writer who loves all things gaming and tech. His journey into the realm of gaming began with a PlayStation 1 but he chose PC as his platform of choice. With over 6 years of ...

Clinical-stage antibody company Generate:Biomedicines is the latest biotech to mull going public as momentum for IPOs continues to build. The Flagship-founded biotech has yet to set out how many ...